QI
DRNA

Quotient Investors’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Quotient Investors’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$111K Hold
19,300
– – 0.08% 139
2017
Q2 		$61K Buy
19,300
+5,700
+42% +$18K 0.04% 146
2017
Q1 		$46K Buy
+13,600
New +$38.3K 0.03% 169

Other funds holding DRNA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Quotient Investors's DRNA Position: Q3 2017 in Review

Quotient Investors held its Dicerna Pharmaceuticals, Inc. (DRNA) position steady in Q3 2017 at 19,300 shares worth $111K. The position accounts for 0.08% of the portfolio, ranked #139.

Quotient Investors first reported a position in DRNA in Q1 2017 and has held it in 3 quarters since. 37 funds tracked by Wall St. Rank hold DRNA as of Q3 2017.

  • Quotient Investors held 19,300 shares of Dicerna Pharmaceuticals, Inc. worth $111K as of Q3 2017.
  • Quotient Investors left its Dicerna Pharmaceuticals, Inc. share count unchanged in Q3 2017.
  • Dicerna Pharmaceuticals, Inc. made up 0.08% of Quotient Investors's portfolio in Q3 2017, its #139 holding.
  • Quotient Investors first reported a position in Dicerna Pharmaceuticals, Inc. in Q1 2017 and has held it in 3 quarters since.
  • 37 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q3 2017.

Based on Quotient Investors's 13F filing for Q3 2017, filed 18 Oct 2017.